BYND

Business Context and Reporting Period

Company: Beyond Meat, Inc. (BYND)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 27, 2025 (Third Quarter 2025)
Business Overview: Beyond Meat is a leading plant-based meat company. The reporting period reflects continued execution of a "Global Operations Review" initiated in 2023, which includes workforce reductions, the suspension of operational activities in China, and a strategic pivot to prioritize gross margin expansion and cash generation amidst weak category demand.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net revenues decreased 13.3% in Q3 and 14.4% YTD compared to the prior year, driven by a 10.3% decrease in volume sold and a 3.5% decrease in net revenue per pound. Weak category demand and reduced distribution points in U.S. retail were primary drivers.
• Impairment Charge: The Company recorded a non-cash impairment loss of $77.4 million in Q3 2025 related to long-lived assets (property, plant, equipment, and lease assets). This was triggered by lower-than-expected performance, a sustained decline in stock price, and the determination that softness in the plant-based meat category would persist longer than anticipated.
• China Operations: Operational activities in China substantially ceased in Q2 2025. This resulted in $1.7 million in accelerated depreciation in Q3 and $4.9 million YTD, with an estimated total of $13.0–$14.0 million in charges expected through 2026.
• Debt Restructuring (Subsequent Event): Following the quarter end, the Company completed an Exchange Offer, exchanging approximately 97.44% of its 2027 Notes for new 2030 Notes and common stock. Additionally, the Company drew the full $100 million under a new Delayed Draw Term Loan facility.

Guidance, Outlook, and Risks

• Liquidity Outlook: Management believes existing cash balances and anticipated cash flows will fund operations for the next twelve months. However, the Company expects to continue operating at a loss and may seek additional capital through equity or debt issuance, which could result in dilution.
• Cost Reduction: The Company continues to execute cost-reduction initiatives, including workforce reductions (approx. 40 employees in North America in August 2025) and real estate optimization (partial lease termination and subleasing of Campus Headquarters).
• Material Weakness in Internal Controls: Management identified a material weakness in internal control over financial reporting related to the accounting for non-recurring and complex transactions (compensation, debt, lease, and warrant transactions). Disclosure controls and procedures were deemed ineffective as of September 27, 2025.
• Regulatory Risks: Ongoing litigation and regulatory scrutiny regarding the use of "meat" terminology in plant-based products in the EU, France, and other jurisdictions. The Company recently won a significant legal victory in France regarding the "Contested Decree" but faces new legislative proposals at the EU level.
• Subsequent Equity Sales: Post-quarter, the Company sold approximately 58.9 million shares under its ATM program for net proceeds of $148.7 million.

Investor Verification Checklist

• Impairment Details: Verify the specific asset groups impacted by the $77.4 million impairment and the assumptions used in the fair value assessment.
• Debt Covenants: Review the covenants in the new 2030 Notes and the Loan and Security Agreement, specifically the minimum liquidity requirement of $15.0 million and restrictions on cash interest payments.
• China Exit Costs: Monitor the realization of the estimated $13.0–$14.0 million in total charges related to the China suspension through 2026.
• Internal Control Remediation: Track the progress of the remediation plan for the material weakness in internal controls to ensure future financial reporting reliability.
• Stock Dilution: Assess the impact of the Exchange Offer (issuance of ~318 million new shares) and potential future conversions of the 2030 Notes on existing shareholder value.